{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T22:49:22Z","timestamp":1665614962210},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm Res"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.1007\/bf01630481","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T16:33:34Z","timestamp":1115397214000},"page":"16-20","source":"Crossref","is-referenced-by-count":3,"title":["Effects of topical antiinflammatory agents on Freund's adjuvant-induced skin lesions in rats"],"prefix":"10.1007","volume":"44","author":[{"given":"Gerard J.","family":"Gendimenico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Mezick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0076-6879(88)62089-1","volume":"162","author":"JD Taurog","year":"1988","unstructured":"Taurog JD, Argentieri DC, McReynolds RA. Adjuvant arthritis. Meth Enzymol 1988;162:339\u201355.","journal-title":"Meth Enzymol"},{"key":"CR2","first-page":"363","volume-title":"Pharmacological Methods in the Control of Inflammation","author":"BM Weichman","year":"1989","unstructured":"Weichman BM. Rat adjuvant arthritis: A model of chronic inflammation. In: Chang JY, Lewis A, editors. Pharmacological Methods in the Control of Inflammation. New York: Alan R. Liss, 1989:363\u201380."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1084\/jem.113.3.485","volume":"113","author":"CM Pearson","year":"1961","unstructured":"Pearson CM, Waksman BH, Sharp JT. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes: comparison of the experimental process with human disease. J Exp Med 1961;113:485\u2013510.","journal-title":"J Exp Med"},{"key":"CR4","first-page":"215","volume-title":"Cutaneous models of inflammation for the evaluation of topical and systemic pharmacological agents","author":"JM Young","year":"1989","unstructured":"Young JM, De Young LM. Cutaneous models of inflammation for the evaluation of topical and systemic pharmacological agents. In: Change JY, Lewis A, editors. New York: Alan R. Liss, 1989:215\u201331."},{"key":"CR5","first-page":"1572","volume-title":"The Pharmacological Basis of Therapeutics","author":"MM Chren","year":"1990","unstructured":"Chren MM, Bickers DR. Dermatological pharmacology. 8th ed. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990:1572\u201391.","edition":"8th ed."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1001\/jama.1986.03380220076026","volume":"256","author":"CN Ellis","year":"1986","unstructured":"Ellis CN, Gorsulowsky DC, Hamilton TA, Billings JK, Brown MD, Headington JT, et al. Cyclosporine improves psoriasis in a double-blind study. JAMA 1986;256:3110\u20136.","journal-title":"JAMA"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2133.1988.tb01772.x","volume":"118","author":"T Joost Van","year":"1988","unstructured":"Van Joost T, Bos JD, Heule F, Meinardi MMHM. Low-dose cyclosporin A in severe psoriasis. A double-blind study. Br J Dermatol 1988;118:183\u201390.","journal-title":"Br J Dermatol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","volume":"338","author":"JM Sowden","year":"1991","unstructured":"Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137\u201340.","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000210782","volume":"1","author":"RC Hermann","year":"1988","unstructured":"Hermann RC, Taylor RS, Ellis CN, Williams NA, Weiner ND, Flynn GL, et al. Topical ciclosporin for psoriasis: in vitro skin penetration and clinical study. Skin Pharmacol 1988;1:246\u20139.","journal-title":"Skin Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archderm.1992.01680160070006","volume":"128","author":"MK Burns","year":"1992","unstructured":"Burns MK, Ellis CN, Eisen D, Duell E, Griffiths CEM, Annesley TN et al. Intralesional cyclosporine for psoriasis: relationship of dose, tissue levels, and efficacy. Arch Dermatol 1992;128:786\u201390.","journal-title":"Arch Dermatol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0190-9622(86)70004-2","volume":"14","author":"CN Ellis","year":"1986","unstructured":"Ellis CN, Fallon JD, Kang S, Vanderveen EE, Voorhees JJ. Topical application of nonsteroidal anti-inflammatory drugs prevents vehicle-induced improvement of psoriasis. J Am Acad Dermatol 1986;14:39\u201343.","journal-title":"J Am Acad Dermatol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01966592","volume":"17","author":"RP Carlson","year":"1985","unstructured":"Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 1985;17:197\u2013204.","journal-title":"Agents Actions"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF01965041","volume":"25","author":"RJ Griffiths","year":"1988","unstructured":"Griffiths RJ, Wood BE, Li S, Blackham A. Pharmacological modification of 12-O-tetradecanoylphorbol-13-acetate induced inflammation and epidermal cell proliferation in mouse skin. Agents Actions 1988;25:344\u201351.","journal-title":"Agents Actions"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF01967298","volume":"26","author":"LM Young De","year":"1989","unstructured":"De Young LM, Kheifets JB, Ballaron SJ, Young JM. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions 1989;26:335\u201341.","journal-title":"Agents Actions"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000210960","volume":"4","author":"PL Stanley","year":"1991","unstructured":"Stanley PL, Steiner S, Havens M, Tramposch KM. Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacol 1991;4:262\u201371.","journal-title":"Skin Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/0006-2952(88)90704-6","volume":"37","author":"R Meurer","year":"1988","unstructured":"Meurer R, Opas EE, Humes JL. Effects of cyclooxygenase and lipoxygenase inhibitors on inflammation associated with oxazolone-induced delayed hypersensitivity. Biochem Pharmacol 1988;37:3511\u20134.","journal-title":"Biochem Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0090-1229(80)90024-0","volume":"15","author":"JS Goodwin","year":"1980","unstructured":"Goodwin JS, Webb DR. Regulation of the immune response by prostaglandins. Clin Immunol Immunopath 1980;15:106\u201322.","journal-title":"Clin Immunol Immunopath"},{"key":"CR18","first-page":"441","volume":"13","author":"CEM Griffiths","year":"1992","unstructured":"Griffiths CEM, Voorhees JJ. Immunological mechanisms involved in psoriasis. Springer Semin Immunopathol 1992;13:441\u201354.","journal-title":"Springer Semin Immunopathol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1523-1747.ep12371746","volume":"102","author":"KD Cooper","year":"1994","unstructured":"Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128\u201337.","journal-title":"J Invest Dermatol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1986.tb01161.x","volume":"94","author":"IR Cohen","year":"1986","unstructured":"Cohen IR. Regulation of autoimmune disease physiological and therapeutic. Immunol Rev 1986;94:5\u201321.","journal-title":"Immunol Rev"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01630481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01630481\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01630481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:38:56Z","timestamp":1557254336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01630481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["BF01630481"],"URL":"https:\/\/doi.org\/10.1007\/bf01630481","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}